Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halil K Erol

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Thyroid Research|November 6, 2009
Congenital leptin deficiency and thyroid functionGilberto Paz-Filho, Tuncay Delibasi, Halil K Erol, et al.
Plos One|September 5, 2008
Leptin replacement improves cognitive developmentGilberto J Paz-Filho, Talin Babikian, Robert Asarnow, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 17, 2026
Phosphate homeostasis and apparent treatment-resistant hypertension in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) studyAlvin G Kwon, Jiang He, L Lee Hamm, et al.
Plos One|April 28, 2023
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated eraSrilekha Sridhara, Ahmet B Gungor, Halil K Erol, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Thyroid Research|November 6, 2009
Congenital leptin deficiency and thyroid functionGilberto Paz-Filho, Tuncay Delibasi, Halil K Erol, et al.
Plos One|September 5, 2008
Leptin replacement improves cognitive developmentGilberto J Paz-Filho, Talin Babikian, Robert Asarnow, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 17, 2026
Phosphate homeostasis and apparent treatment-resistant hypertension in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) studyAlvin G Kwon, Jiang He, L Lee Hamm, et al.
Plos One|April 28, 2023
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated eraSrilekha Sridhara, Ahmet B Gungor, Halil K Erol, et al.
Pageof 1